Similar articles for PMID: 31478109

Year	Number of Results
2007	2
2009	2
2010	1
2011	1
2012	5
2013	8
2014	16
2015	22
2016	18
2017	25
2018	18
2019	23
2020	19
2021	25
2022	18
2023	16
2024	0

1

Irreversible Electroporation for the Ablation of Prostate Cancer.

Karagiannis A, Varkarakis J. Karagiannis A, et al. Curr Urol Rep. 2019 Sep 2;20(10):63. doi: 10.1007/s11934-019-0929-x. Curr Urol Rep. 2019. PMID: 31478109 Review.

2

Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.

Scheltema MJ, van den Bos W, de Bruin DM, Wijkstra H, Laguna MP, de Reijke TM, de la Rosette JJ. Scheltema MJ, et al. BMC Cancer. 2016 May 5;16:299. doi: 10.1186/s12885-016-2332-z. BMC Cancer. 2016. PMID: 27150293 Free PMC article. Clinical Trial.

3

Focal irreversible electroporation as primary treatment for localized prostate cancer.

van den Bos W, Scheltema MJ, Siriwardana AR, Kalsbeek AMF, Thompson JE, Ting F, Böhm M, Haynes AM, Shnier R, Delprado W, Stricker PD. van den Bos W, et al. BJU Int. 2018 May;121(5):716-724. doi: 10.1111/bju.13983. Epub 2017 Sep 4. BJU Int. 2018. PMID: 28796935 Clinical Trial.

4

Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment.

Blazevski A, Scheltema MJ, Amin A, Thompson JE, Lawrentschuk N, Stricker PD. Blazevski A, et al. BJU Int. 2020 Mar;125(3):369-378. doi: 10.1111/bju.14951. Epub 2019 Dec 5. BJU Int. 2020. PMID: 31725935 Review.

5

Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.

Scheltema MJ, van den Bos W, Siriwardana AR, Kalsbeek AMF, Thompson JE, Ting F, Böhm M, Haynes AM, Shnier R, Delprado W, Stricker PD. Scheltema MJ, et al. BJU Int. 2017 Nov;120 Suppl 3:51-58. doi: 10.1111/bju.13991. Epub 2017 Sep 19. BJU Int. 2017. PMID: 28834167

6

Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control: A Randomized Clinical Trial.

Zhang K, Teoh J, Laguna P, Dominguez-Escrig J, Barret E, Ramon-Borja JC, Muir G, Bohr J, de Reijke TM, Pelechano Gómez P, Ng CF, Sanchez-Salas R, de la Rosette J. Zhang K, et al. JAMA Surg. 2023 Apr 1;158(4):343-349. doi: 10.1001/jamasurg.2022.7516. JAMA Surg. 2023. PMID: 36723911 Free PMC article.

7

Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort.

Blazevski A, Scheltema MJ, Yuen B, Masand N, Nguyen TV, Delprado W, Shnier R, Haynes AM, Cusick T, Thompson J, Stricker P. Blazevski A, et al. Eur Urol Oncol. 2020 Jun;3(3):283-290. doi: 10.1016/j.euo.2019.04.008. Epub 2019 May 16. Eur Urol Oncol. 2020. PMID: 31103721

8

The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.

van den Bos W, de Bruin DM, Muller BG, Varkarakis IM, Karagiannis AA, Zondervan PJ, Laguna Pes MP, Veelo DP, Savci Heijink CD, Engelbrecht MRW, Wijkstra H, de Reijke TM, de la Rosette JJMCH. van den Bos W, et al. BMJ Open. 2014 Oct 29;4(10):e006382. doi: 10.1136/bmjopen-2014-006382. BMJ Open. 2014. PMID: 25354827 Free PMC article.

9

Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings during follow up.

Beyer LP, Pregler B, Nießen C, Michalik K, Haimerl M, Stroszczynski C, Jung EM, Wiggermann P. Beyer LP, et al. Clin Hemorheol Microcirc. 2016;64(3):501-506. doi: 10.3233/CH-168125. Clin Hemorheol Microcirc. 2016. PMID: 27935553

10

[Irreversible electroporation. Current value for focal treatment of prostate cancer].

Wendler JJ, Ganzer R, Hadaschik B, Blana A, Henkel T, Köhrmann KU, Machtens S, Roosen A, Salomon G, Sentker L, Witzsch U, Schlemmer HP, Baumunk D, Köllermann J, Schostak M, Liehr UB; Working Group for Focal and Microtherapy, Academy of the German Society of Urology. Wendler JJ, et al. Urologe A. 2015 Jun;54(6):854-62. doi: 10.1007/s00120-015-3864-6. Urologe A. 2015. PMID: 26024649 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

191 results

Results by year